Astellas Pharma (United Kingdom)

London (United Kingdom gb)
Epidemiology
Mirabegron Solifenacin Overactive Bladder Fidaxomicin Enzalutamide Tolterodine Tacrolimus Pharmacogenetics Vasomotor Metastatic Prostate Cancer Clinical endpoint
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

541
Activity
3%

Total documents

1.74
Impact
3%

Normalized Impact

83
Excellence
3%

Highly Cited Papers (Top 10%)

64.7
Leadership
3%

Leadership (%)

80.6
Mobility & Collaboration
3%

International Collaboration (%)

15
Excellence
3%

Outstanding papers (Top 1%)

14.8
Leadership
3%

Women Leading (%)

12.2
Leadership
3%

Women Leading International (%)

69.9
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Siddiqui, Emad male Urology Senior researcher 806 22 106 1.93 21 33.0% 51.9%
2 Nazir, Jameel male Urology Senior researcher 731 21 112 0.93 8 31.3% 67.0%
3 Longshaw, Christopher male Molecular Medicine, Pharmacology, Infectious Diseases Senior researcher 730 27 72 2.71 19 22.2% 52.8%
4 Isaac A. O. Odeyemi Epidemiology, Urology Leading researcher 687 30 119 0.77 9 34.5% 39.5%
5 Morga, Antonia female Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Hematology, Pathology and Forensic Medicine Researcher 587 14 32 1.05 4 46.9% 84.4%
6 Blogg, Martin male Physiology Senior researcher 566 22 45 2.58 12 20.0% 77.8%
7 Undre, Nasrullah female Transplantation Leading researcher 562 44 79 1.48 12 58.2% 57.0%
8 Mankowski, Colette female Urology, Rheumatology, Epidemiology Occasional author 557 9 7 1.42 1 57.1% 57.1%
9 Huang, Moses male Urology Researcher 545 21 28 2.65 7 10.7% 53.6%
10 Compion, Gerhard male Urology Researcher 518 19 23 2.03 4 47.8% 34.8%
11 Gbenga R. Kazeem Surgery Senior researcher 496 22 45 1.38 7 6.7% 71.1%
12 Ali, Mahmood male Urology, Epidemiology, Rheumatology Researcher 476 6 9 0.65 0 33.3% 77.8%
13 Garnham, Antonio male Surgery, Pulmonary and Respiratory Medicine Leading researcher 476 36 81 0.75 5 21.0% 24.7%
14 Todorova, Lora female Endocrinology, Diabetes and Metabolism Leading researcher 464 57 68 0.73 8 57.4% 39.7%
15 Stari, Anny female Urology Occasional author 434 10 7 0.73 0 0.0% 57.1%
16 Tahir, Saleem male Cardiology and Cardiovascular Medicine, Urology Researcher 425 35 17 9.35 3 23.5% 29.4%
17 Stow, Bridget female Rheumatology, Urology Occasional author 423 12 5 2.17 1 0.0% 40.0%
18 Chilelli, Andrew male Pulmonary and Respiratory Medicine Junior researcher 418 4 7 0.44 0 57.1% 28.6%
19 Nurul Hoque Choudhury Urology Senior researcher 416 55 30 1.43 6 23.3% 60.0%
20 Andreas J. Karas Infectious Diseases, Epidemiology Researcher 404 21 23 2.54 7 21.7% 69.6%
21 Anaokar, Swapneel male Transplantation Researcher 397 6 8 0.52 0 0.0% 100.0%
22 Ingrid Van Der Putten‐Slob Urology Occasional author 384 20 5 2.30 1 40.0% 60.0%
23 Fahey, Amanda female Urology Occasional author 383 16 5 4.73 1 40.0% 20.0%
24 Carola del Pilar Repetur Transplantation, Psychiatry and Mental health Junior researcher 377 2 2 0.43 0 0.0% 100.0%
25 Upadhyay, Anil male Hematology Junior researcher 356 3 5 0.90 1 40.0% 60.0%
806
One Index
 Siddiqui, Emad PhD   0000-0003-4855-8946 106 docs (2003 - 2024)  
Mirabegron , Overactive Bladder , Solifenacin , Tolerability , Tolterodine
731
One Index
 Nazir, Jameel PhD   0000-0002-5854-2502 112 docs (2004 - 2023)  
Mirabegron , Solifenacin , Tolterodine , Overactive Bladder , Oxybutynin
730
One Index
 Longshaw, Christopher PhD   0000-0002-5586-7256 72 docs (1998 - 2024)  
Acinetobacter baumannii , Fidaxomicin , Colistin , Broth microdilution , Carbapenem
687
One Index
 Isaac A. O. Odeyemi PhD 119 docs (1995 - 2024)  
Overactive Bladder , Solifenacin , Tolterodine , Mirabegron , Tacrolimus Pharmacogenetics
587
One Index
 Morga, Antonia PhD   0009-0008-6671-5056 32 docs (2011 - 2024)  
Vasomotor , Vasomotor Symptoms , Menopause , Health Technology Assessment , Nice
566
One Index
 Blogg, Martin PhD 45 docs (2003 - 2024)  
Omalizumab , Treatment , Asthma , Allergic asthma , Concomitant
562
One Index
 Undre, Nasrullah PhD   0000-0001-7294-7883 79 docs (1981 - 2024)  
Tacrolimus Pharmacogenetics , Immunosuppression , Trough level , Echinocandin , Antifungal Therapy
557
One Index
 Mankowski, Colette 7 docs (2016 - 2018)  
Solifenacin , Tolterodine , Oxybutynin , Pregabalin , Tolerability
545
One Index
 Huang, Moses PhD 28 docs (2004 - 2019)  
Mirabegron , Solifenacin , Overactive Bladder , Tolterodine , Urination
518
One Index
 Compion, Gerhard PhD 23 docs (2006 - 2015)  
Solifenacin , Overactive Bladder , Oxybutynin , Tolterodine , Detrusor Overactivity
496
One Index
 Gbenga R. Kazeem PhD 45 docs (2003 - 2024)  
Tacrolimus Pharmacogenetics , Fidaxomicin , Clinical endpoint , Regimen , Immunosuppression
476
One Index
 Ali, Mahmood PhD   0000-0003-3099-1776 9 docs (2019 - 2023)  
Mirabegron , Pharmacotherapy , Solifenacin , Overactive Bladder , Neurogenic Lower Urinary Tract Dysfunction
476
One Index
 Garnham, Antonio PhD   0009-0003-8160-2870 81 docs (1989 - 2024)  
Mirabegron , Tolterodine , FLT3 Mutations , Overactive Bladder , Cardiovascular Evaluation
464
One Index
 Todorova, Lora PhD   0000-0002-5667-5707 68 docs (1968 - 2024)  
Diabetes , Chronic pyelonephritis , Continuous Glucose Monitoring , Vasomotor , Type 1 Diabetes
434
One Index
 Stari, Anny 7 docs (2015 - 2019)  
Mirabegron , Overactive Bladder , Persistence (discontinuity) , Metastatic Prostate Cancer , Post-hoc analysis
425
One Index
 Tahir, Saleem PhD 17 docs (1990 - 2020)  
Mirabegron , Solifenacin , Overactive Bladder , Encephalopathy , Cardiac Metabolism
423
One Index
 Stow, Bridget 5 docs (2013 - 2015)  
Solifenacin , Overactive Bladder , Detrusor Overactivity , Oxybutynin , Transvaginal ultrasound
418
One Index
 Chilelli, Andrew 7 docs (2021 - 2024)  
Enzalutamide , Metastatic Prostate Cancer , Abiraterone acetate , Abiraterone , Metabolic Reprogramming
416
One Index
 Nurul Hoque Choudhury PhD 30 docs (1970 - 2022)  
Mirabegron , Overactive Bladder , Solifenacin , Tamsulosin , Neurogenic Lower Urinary Tract Dysfunction
404
One Index
 Andreas J. Karas PhD 23 docs (2004 - 2023)  
Fidaxomicin , Vancomycin and Metronidazole Treatment , Clinical endpoint , Regimen , Clostridioides
397
One Index
 Anaokar, Swapneel PhD 8 docs (2019 - 2024)  
Tacrolimus Pharmacogenetics , Immunosuppression , Kidney Transplantation , Clinical endpoint , Interim analysis
384
One Index
 Ingrid Van Der Putten‐Slob 5 docs (2005 - 2013)  
Tolerability , Tamsulosin , Clinical endpoint , Overactive Bladder , Lower Urinary Tract Symptoms
383
One Index
 Fahey, Amanda 5 docs (2009 - 2024)  
Tolterodine , Persistence (discontinuity) , Overactive Bladder , Solifenacin , Oxybutynin
377
One Index
 Carola del Pilar Repetur 2 docs (2023 - 2024)  
Kidney Transplantation , Tacrolimus Pharmacogenetics , Clinical endpoint
356
One Index
 Upadhyay, Anil 5 docs (2022 - 2024)  
FLT3 Mutations , Acute Myeloid Leukemia , Subclinical infection , Complete blood count , Dengue